A new study published on the preprint server medRxiv* in May 2020 reports a multi-omics approach that could make it easier to develop drugs that are effective against COVID-19. Multi-omics is a ...
Enhanc3D Genomics (‘Enhanced’), an innovator in 3D genomics technology, today announced the launch of a suite of integrated multi-omics solutions to accelerate and improve the precision of drug ...
Melyssa Minto (left) is an omics researcher and bioinformatics scientist at RTI International (NC, USA), where she uses multiomic data to understand how the central dogma of biology – the way genetic ...
Enhanc3D Genomics has announced the launch of a suite of integrated multi-omics solutions to accelerate and improve the precision of drug discovery. The new 3D multi-omics offerings were designed to ...
Phase 1a/1b study in 97 patients demonstrates mitochondrial metabolic reprogramming induced by BPM31510-IV and supports advancement in multiple aggressive solid tumor indications. BPM31510-IV has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results